ArticleJCI insight2024

Human-specific elimination of epithelial Siglec-XII suppresses the risk of inflammation-driven colorectal cancers.

Hector A Cuello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.